Literature DB >> 23356500

Serum hepcidin is associated with parameters of glucose metabolism in women with gestational diabetes mellitus.

Aysel Uysal Derbent1, Serap Aynur Simavli, Ikbal Kaygusuz, Ilknur Inegol Gumus, Saynur Yılmaz, Melehat Yildirim, Sema Uysal.   

Abstract

OBJECTIVES: Hepcidin is considered a major regulator of iron metabolism. Despite previous studies showing elevated ferritin and hepcidin levels in type 2 diabetes mellitus (DM), no study has investigated hepcidin levels in pregnant women with gestational DM (GDM).
METHODS: A case-control study was conducted in 30 cases of GDM, 47 pregnant women with impaired glucose tolerance (IGT) and 72 pregnant women with normal glucose tolerance (control) between April 2009 and July 2011. Serum hepcidin and other iron metabolism parameters were analyzed in all groups.
RESULTS: Serum ferritin and serum iron were significantly elevated in the GDM group compared to controls (p = 0.014, p = 0.018, respectively) and to the IGT group (p = 0.021, p = 0.008, respectively). Hepcidin levels were elevated significantly in the diabetic patients compared to the IGT group (p = 0.011) and controls (p = 0.002). We found no correlation between hepcidin and other iron metabolism parameters (Hb, serum iron and ferritin), whereas positive correlations were found between hepcidin and parameters of glucose metabolism (fasting blood glucose, fasting insulin level and glucose value response to glucose challenge test).
CONCLUSIONS: Serum hepcidin concentrations were increased in pregnant women with IGT and GDM and this was not related to inflammation parameters.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23356500     DOI: 10.3109/14767058.2013.770462

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  8 in total

1.  Effect of various doses of vitamin D supplementation on pregnant women with gestational diabetes mellitus: A randomized controlled trial.

Authors:  Qingying Zhang; Yan Cheng; Mulan He; Tingting Li; Ziwen Ma; Haidong Cheng
Journal:  Exp Ther Med       Date:  2016-07-13       Impact factor: 2.447

2.  Prepregnancy Body Mass Index and Gestational Weight Gain Have No Negative Impact on Maternal or Neonatal Iron Status.

Authors:  Chang Cao; Eva K Pressman; Elizabeth M Cooper; Ronnie Guillet; Mark Westerman; Kimberly O O'Brien
Journal:  Reprod Sci       Date:  2015-09-29       Impact factor: 3.060

3.  Supplemental iron intake and the risk of glucose intolerance in pregnancy: re-analysis of a randomised controlled trial in Finland.

Authors:  Tarja I Kinnunen; Riitta Luoto; Annika Helin; Elina Hemminki
Journal:  Matern Child Nutr       Date:  2014-07-04       Impact factor: 3.092

Review 4.  Dietary iron intake, iron status, and gestational diabetes.

Authors:  Cuilin Zhang; Shristi Rawal
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

Review 5.  Iron, oxidative stress and gestational diabetes.

Authors:  Taifeng Zhuang; Huijun Han; Zhenyu Yang
Journal:  Nutrients       Date:  2014-09-25       Impact factor: 5.717

Review 6.  Iron Status and Gestational Diabetes-A Meta-Analysis.

Authors:  Yachana Kataria; Yanxin Wu; Peter de Hemmer Horskjær; Thomas Mandrup-Poulsen; Christina Ellervik
Journal:  Nutrients       Date:  2018-05-15       Impact factor: 5.717

Review 7.  Iron Therapeutics in Women's Health: Past, Present, and Future.

Authors:  Joel Mintz; Jackie Mirza; Eric Young; Kyle Bauckman
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-08

Review 8.  The Relationship Between Body Iron Status, Iron Intake And Gestational Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Shimin Fu; Feifei Li; Jianguo Zhou; Zhiping Liu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.